 SOUTH SAN FRANCISCO, Calif., July 29, 2021 GLOBE NEWSWIRE -- Aligos Therapeutics, Inc. Nasdaq: ALGS, a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that it will report the companys second quarter 2021 financial results on Thursday, August 5, 2021 after the close of U.S. financial markets. 